7,511
Views
55
CrossRef citations to date
0
Altmetric
Research Article

Triterpenoids and polysaccharide peptides-enriched Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study of its antioxidation and hepatoprotective efficacy in healthy volunteers

, , , , , , & show all
Pages 1041-1046 | Received 12 Aug 2016, Accepted 25 Jan 2017, Published online: 09 Feb 2017

References

  • Aebi H. 1984. Catalase in vitro. Meth Enzymol.105:121–126.
  • Arnao MB, Casas JL, Del Rio JA, Acosta M. Garcia-Canovas 1990. An enzymatic colorimetric method for measuring naringin using 2,20-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) in the presence of peroxidase. Anal Biochem. 185:335–338.
  • Bao XF, Wang XS, Dong Q, Fang JN, Li XY. 2002. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry. 59:175–181.
  • Boh B, Berovic M, Zhang J, Zhi-Bin L. 2007. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev. 13:265–301.
  • Chu TT, Benzie IF, Lam CW, Fok BS, Lee KK, Tomlinson B. 2012. Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. Br J Nutr. 107:1017–1027.
  • Deepalakshmi K, Mirunalini S. 2011. Therapeutic properties and current medical usage of medicinal mushroom: Ganoderma lucidum. Int J Pharm Sci Res. 2:1922–1929.
  • Draper HH, Hadley M. 1989. Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol.186:421–431.
  • Gao Y, Zhou S. 2009. Cancer prevention and treatment by Ganoderma, a mushroom with medicinal properties. Food Rev Int. 19:275–325.
  • Halliwell B, Gutteridge JM. 1990. The antioxidants of human extracellular fluids. Arch Biochem Biophys. 280:1–8.
  • Hamvas A, Palazzo R, Kaiser L, Cooper J, Shuman T, Velazquez M, Freeman B, Schuster DP. 1992. Inflammation and oxygen free radical formation during pulmonary ischemia-reperfusion injury. J Appl Physiol. 72:621–628.
  • Han HF, Nakamura N, Hattori M. 2006. Protective effects of an acidic polysaccharide isolated from fruiting bodies of Ganoderma lucidum against murine hepatic injury induced by Propionibacterium acnes and lipopolysaccharide. J Nat Med. 60:295–302.
  • Hu ML. 1994. Measurement of protein thiol groups and glutathione in plasma. Meth Enzymol. 233:380–385.
  • Iranzo O. 2011. Manganese complexes displaying superoxide dismutase activity: a balance between different factors. Bioorg Chem. 39:73–87.
  • Jia J, Zhang X, Hu YS, Wu Y, Wang QZ, Li NN, Guo QC, Dong XC. 2009. Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats. Food Chem. 115:32–36.
  • Kamesh V, Sumathi T. 2014. Nephroprotective potential of Bacopa monniera on hypercholesterolemia induced nephropathy via the NO signaling pathway. Pharm Biol. 52:1327–1334.
  • Ko HH, Hung CF, Wang JP, Lin CN. 2008. Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry. 69:234–239.
  • Lai CSW, Yu MS, Yuen WH, So KF, Zee SY, Chang RCC. 2008. Antagonizing beta-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res. 1190:215–224.
  • Lee JM, Kwon H, Jeong H, Lee JW, Lee Y, Baek SJ, Surh YJ. 2001. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res. 15:245–249.
  • Li HJ, He YL, Zhang DH, Yue TH, Jiang LX, Li N, Xu JW. 2016. Enhancement of ganoderic acid production by constitutively expressing Vitreoscilla hemoglobin gene in Ganoderma lucidum. J Biotechnol. 227:35–40.
  • Liu LY, Chen H, Liu C, Wang HQ, Kang J, Li Y, Chen RY. 2014. Triterpenoids of Ganoderma theaecolum and their hepatoprotective activities. Fitoterapia. 98:254–259.
  • Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 84:407–412.
  • Olmez I, Ozyurt H. 2012. Reactive oxygen species and ischemic cerebrovascular disease. Neurochem Int. 60:208–212.
  • Pan D, Zhang D, Wu J, Chen C, Xu Z, Yang H, Zhou P. 2013. Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from Ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism. PLoS One. 8:e68332
  • Pandey KB, Rizvi SI. 2010. Markers of oxidative stress in erythrocytes and plasma during aging in humans. Oxid Med Cell Longev. 3:2–12.
  • Rattan SIS. 2006. Theories of biological aging: genes, proteins, and free radicals. Free Radic Res. 40:1230–1238.
  • Rubel R, Dalla Santa HS, Fernandes LC, Bonatto SJR, Bello S, Figueiredo BC, Lima Filho JHC, Santos CAM, Soccol CR. 2011. Hypolipidemic and antioxidant properties of Ganoderma lucidum (Leyss:Fr) Karst used as a dietary supplement. World J Microbiol Biotechnol. 27:1083–1089.
  • Sheena N, Ajith TA, Janardhanan KK. 2003. Anti-inflammatory and anti-nociceptive activities of Ganoderma lucidum occurring in South India. Pharm Biol. 41:301–304.
  • Shi Y, Sun J, He H, Guo H, Zhang S. 2008. Hepatoprotective effects of Ganoderma lucidum peptides against d-galactosamine-induced liver injury in mice. J Ethnopharmacol. 117:415–419.1
  • Valavanidis A, Vlachogianni T, Fiotakis C. 2009. 8-Hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 27:120–139.
  • Wachtel-Galor S, Szeto YT, Tomlinson B, Benzie IFF. 2004a. Ganoderma lucidum ('Lingzhi'); acute and short-term biomarker response to supplementation. Int J Food Sci Nutr. 55:75–83.
  • Wachtel-Galor S, Tomlinson B, Benzie IFF. 2004b. Ganoderma lucidum (‘Lingzhi’), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr. 91:263–269.
  • Wang XM, Yang M, Guan SH, Liu RX, Xia JM, Bi KS, Guo DA. 2006. Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography. J Pharma Biomed Anal. 41:838–844.
  • Wu JG, Kan YJ, Wu YB, Yi J, Chen TQ, Wu JZ. 2016. Hepatoprotective effect of Ganoderma triterpenoids against oxidative damage induced by tert-butyl hydroperoxide in human hepatic HepG2 cells. Pharm Biol. 54:919–929.
  • Yang M, Wang X, Guan S, Xia J, Sun J, Guo H, Guo DA. 2007. Analysis of triterpenoids in Ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry. J Am Soc Mass Spectrom.18:927–939.
  • Yang HL. 2005. Ganoderic acid produced from submerged culture of Ganoderma lucidum induces cell cycle arrest and cytotoxicity in human hepatoma cell line BEL7402. Biotechnol Lett. 27:835–838.